Kitea Closed a $13M investment round, and just like that… 2025 is complete

“As the year comes to a close, I feel incredibly proud of what the Kitea Health team has achieved. This year, we moved into our new facility at Future House Parnell, grew our team, shared our first clinical data around the world, and took major steps forward with regulators in the United States. Our devices continue to perform safely for patients of all ages, and the feedback from surgeons has been deeply encouraging. None of this happens without belief, support, and an amazing team behind it. Finally, we've just closed a $13M investment round; more details in 2026. Thank you to everyone who has backed us and walked this journey with us. We are just getting started.” – Simon Malpas, CEO and Co-founder

Kitea Health Opens New Facility to Advance Brain Care

Kitea Health has announced the opening of its new state-of-the-art facility, marking a significant milestone in its commitment to innovation, quality care, and improving the way chronic care is managed.

Designed with a strong focus on safety and reliability, the facility operates under ISO 13485 and GMP standards. It has the capacity to produce up to 10,000 Kitea Systems annually, supporting chronic care management while also contributing to the local economy. The company’s micro implantable brain device, the first of its kind in New Zealand and the first in the world, will now be delivered to patients with even greater consistency and quality through this new production space.

Beyond manufacturing, the facility serves as a collaborative hub, bringing together healthcare professionals and research partners. It is intended to foster innovation, encourage the exchange of ideas, and drive advancements in brain care.

Kitea Health has expressed its gratitude to its team, partners, and supporters who helped make the facility possible. From this new base, the company looks ahead to continuing its mission to improve health management and enhance patient well-being on a global scale.

Behind every statistic is a child. That’s why we do this.

Nationwide Children’s Hospital and the Hydrocephalus Association are uniting global leaders in a pivotal international event dedicated to advancing hydrocephalus care. Professor Simon Malpas, CEO and co-founder of Kitea Health, has been invited as a panellist in Ohio, USA, and will lend his expertise to this groundbreaking gathering.

Backed by the mission of the Hydrocephalus Association to improve the lives of those impacted by the condition, Simon will be sharing how bold innovation and technology are unlocking earlier diagnosis, smarter monitoring, and better outcomes for patients worldwide.

Hosted by Nationwide Children’s Hospital, we to believe that when your child needs a hospital, everything matters. This sees trailblazers working to rewrite the future of hydrocephalus care.

We see the momentum, and we're proud to support it.